Ablation therapy in containing extension of hepatocellular carcinoma: A simulative analysis of dropout from the waiting list for liver transplantation
Noriyo Yamashiki, Ryosuke Tateishi, Haruhiko Yoshida, Shuichiro Shiina, Takuma Teratani, Shinpei Sato, Norio Mine, Yuji Kondo, Takao Kawabe, Masao Omata – 21 April 2005 – The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan criteria with a bridging therapy.